Dupont Capital Management Corp Acadia Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$14.2 - $18.63 $385,757 - $506,102	-27,166 Reduced 67.25%	13,228 $0
Q3 2022 Oct 31, 2022	BUY	$14.11 - $18.27 $282,355 - $365,600	20,011 Added 98.17%	40,394 $661,000
Q1 2022 Apr 27, 2022	SELL	$20.94 - $27.5 $37,754 - $49,582	-1,803 Reduced 8.13%	20,383 $494,000
Q4 2021 Jan 31, 2022	BUY	$16.79 - $27.09 $112,006 - $180,717	6,671 Added 43.0%	22,186 $518,000
Q3 2021 Nov 03, 2021	BUY	$15.78 - $24.77 $244,826 - $384,306	15,515 New	15,515 $258,000
Q2 2021 Jul 30, 2021	SELL	$19.4 - $27.42 $61,847 - $87,414	-3,188 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$25.02 - $54.99 $179,668 - $394,883	-7,181 Reduced 69.25%	3,188 $82,000
Q4 2020 Jan 28, 2021	BUY	$41.04 - $56.79 $117,087 - $162,021	2,853 Added 37.96%	10,369 $554,000
Q3 2020 Oct 29, 2020	BUY	$36.42 - $57.0 $162,214 - $253,878	4,454 Added 145.46%	7,516 $310,000
Q2 2020 Jul 24, 2020	SELL	$39.26 - $52.73 $629,730 - $845,789	-16,040 Reduced 83.97%	3,062 $148,000
Q1 2020 Apr 29, 2020	SELL	$31.65 - $46.87 $76,086 - $112,675	-2,404 Reduced 11.18%	19,102 $807,000
Q4 2019 Jan 27, 2020	BUY	$36.21 - $51.4 $133,433 - $189,409	3,685 Added 20.68%	21,506 $920,000
Q3 2019 Oct 28, 2019	SELL	$22.22 - $44.01 $42,462 - $84,103	-1,911 Reduced 9.68%	17,821 $641,000
Q2 2019 Jul 30, 2019	BUY	$23.32 - $28.12 $460,150 - $554,863	19,732 New	19,732 $527,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.